PTCT
$59.24-2.87%
PTC Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.009%Russell 3000 0.009%
PTCT financial statements
The full income statement, balance sheet, and cash-flow statement for PTC Therapeutics Inc. (PTCT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 76.9M2024-09 77.1M2024-12 78.9M2025-03 79.3M2025-06 79.4M2025-09 80.3M2025-12 82.8M2026-03 82.9M2026-06 83.5M+8.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.73B+114.5% | 807M-14.0% | 938M+34.2% | 699M+29.7% | 539M+41.4% | |
| 864M-22.1% | 1.11B-19.5% | 1.38B+20.2% | 1.15B+25.5% | 913M+12.4% | ||
| Research & development | 455M-14.8% | 534M-19.8% | 667M+2.3% | 651M+20.5% | 541M+13.2% | |
| Selling, general & administrative | 347M+15.4% | 301M-9.5% | 333M+2.0% | 326M+14.1% | 286M+16.6% | |
| Amortization of intangibles | 24.7M-59.3% | 60.7M-72.7% | 223M+91.0% | 117M+112.9% | 54.8M+48.4% | |
| Provision for credit losses | 12.2M+617.6% | 1.70M+88.9% | 900K+350.0% | 200K+100.0% | 100K | |
| Operating income | 867M+386.5% | -303M+31.2% | -440M+1.8% | -447M-19.5% | -374M+13.3% | |
| Other non-operating income | -18.1M-376.4% | 6.54M-35.4% | 10.1M+120.6% | -49.2M+15.0% | -57.9M-167.9% | |
| Gain (loss) on equity securities | 3.96M+54.0% | 2.57M+2.2% | 2.52M+131.5% | -7.99M-577.7% | 1.67M-88.3% | |
| Pre-tax income | 697M+291.8% | -363M+47.8% | -696M-18.5% | -587M-13.3% | -518M-28.6% | |
| Income tax | 14.0M+7840.3% | 176K+100.3% | -69.5M-144.1% | -28.5M-612.0% | 5.56M-84.2% | |
| 683M+287.9% | -363M+42.0% | -627M-12.1% | -559M-6.7% | -524M-19.6% | ||
| Net income to common | 683M+287.9% | -363M+42.0% | -627M-12.1% | -559M-6.7% | -524M-19.6% | |
| $7.78+264.5% | -$4.73+43.5% | -$8.37-7.4% | -$7.79-4.8% | -$7.43-11.9% | ||
| EPS (basic) | $8.58+281.4% | -$4.73+43.5% | -$8.37-7.4% | -$7.79-4.8% | -$7.43-11.9% | |
| Weighted-avg shares (basic) | 79.5M+3.5% | 76.8M+2.7% | 74.8M+4.3% | 71.7M+1.8% | 70.5M+6.7% | |
| Weighted-avg shares (diluted) | 88.3M+14.9% | 76.8M+2.7% | 74.8M+4.3% | 71.7M+1.8% | 70.5M+6.7% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.27B+66.5% | 1.37B+12.1% | 1.22B+75.6% | 694M-27.3% | 954M-22.5% | ||
| Cash & equivalents | 985M+26.3% | 780M+31.3% | 594M+112.3% | 280M+47.5% | 190M-9.1% | |
| Short-term investments | 961M+166.9% | 360M+27.3% | 283M+116.0% | 131M-77.6% | 584M-34.8% | |
| Accounts receivable | 182M+14.5% | 159M-1.4% | 161M+3.3% | 156M+40.9% | 110M+58.0% | |
| Inventory | 79.6M+243.4% | 23.2M-24.1% | 30.6M+40.2% | 21.8M+37.5% | 15.9M-15.2% | |
| Prepaid expenses | 67.3M+52.7% | 44.1M-70.7% | 150M+42.4% | 106M+93.2% | 54.7M+38.5% | |
| 2.90B+70.0% | 1.71B-10.1% | 1.90B+11.1% | 1.71B-12.0% | 1.94B-12.2% | ||
| Property, plant & equipment | 55.4M-9.2% | 61.0M-30.0% | 87.1M+20.0% | 72.6M+38.0% | 52.6M+55.4% | |
| Operating lease right-of-use | 80.1M+41.2% | 56.7M-38.3% | 91.9M-10.3% | 102M+32.3% | 77.4M-8.3% | |
| Goodwill | 82.3M+0.0% | 82.3M+0.0% | 82.3M+0.0% | 82.3M+0.0% | 82.3M+0.0% | |
| Intangible assets | 389M+227.2% | 119M-68.7% | 379M-46.2% | 706M-2.6% | 725M+1.3% | |
| 968M+66.7% | 581M-3.7% | 603M+48.5% | 406M-20.2% | 509M+83.7% | ||
| Accounts payable | 45.5M+163.3% | 17.3M+185.8% | 6.04M-77.8% | 27.3M+18.4% | 23.0M+23.4% | |
| Accrued liabilities | 381M+25.3% | 304M-22.4% | 392M+22.4% | 320M+10.9% | 289M+19.2% | |
| Deferred revenue | 2.04M-62.9% | 5.50M+587.3% | 801K-40.7% | 1.35M | — | |
| Short-term & current debt | 287M | — | — | — | 150M | |
| Current lease liability | 12.5M+20.5% | 10.4M-20.3% | 13.0M+38.8% | 9.37M+28.8% | 7.27M-2.6% | |
| Other current liabilities | — | — | — | — | 1.46M+16.8% | |
| Finance lease liability (current) | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M+135.1% | |
| 3.10B+10.7% | 2.80B+3.3% | 2.71B+32.2% | 2.05B+6.0% | 1.94B+12.2% | ||
| Long-term debt | — | 285M+0.4% | 284M-50.3% | 572M+102.8% | 282M-8.8% | |
| Non-current lease liability | 93.6M+24.9% | 74.9M-23.2% | 97.6M-3.2% | 101M+37.0% | 73.6M-7.4% | |
| Operating lease liability (total) | 106M+24.3% | 85.3M-22.9% | 111M+0.4% | 110M+36.3% | 80.9M-7.0% | |
| Finance lease liability (total) | 6.00M-67.7% | 18.6M-8.0% | 20.2M-6.9% | 21.7M-6.0% | 23.1M-5.2% | |
| Finance lease liability | 3.00M-80.7% | 15.6M-9.4% | 17.2M-8.0% | 18.7M-6.9% | 20.1M-13.0% | |
| Deferred tax liabilities | — | — | 55.9M-45.6% | 103M-25.0% | 137M+0.3% | |
| Other non-current liabilities | 13.7M-36.0% | 21.4M+15095.7% | 141K-94.7% | 2.64M | — | |
| -205M+81.3% | -1.10B-34.1% | -819M-135.8% | -347M-24236.7% | 1.44M-99.7% | ||
| Common stock | 80.0K+3.9% | 77.0K+2.7% | 75.0K+4.2% | 72.0K+1.4% | 71.0K+1.4% | |
| Additional paid-in capital | 2.75B+6.7% | 2.57B+4.4% | 2.47B+7.0% | 2.31B+8.5% | 2.12B-2.2% | |
| Retained earnings | -2.96B+18.7% | -3.65B-11.1% | -3.28B-23.6% | -2.66B-26.6% | -2.10B-28.8% | |
| Accumulated other comprehensive income | 10.5M+140.6% | -25.9M-1914.5% | -1.28M-126.8% | 4.80M+119.8% | -24.3M+60.2% | |
| Total liabilities & equity | 2.90B+70.0% | 1.71B-10.1% | 1.90B+11.1% | 1.71B-12.0% | 1.94B-12.2% | |
| Common shares issued | 81.5M+4.9% | 77.7M+2.6% | 75.7M+3.6% | 73.1M+3.2% | 70.8M+1.6% | |
| Common shares outstanding | 81.5M+4.9% | 77.7M+2.6% | 75.7M+3.6% | 73.1M+3.2% | 70.8M+1.6% | |
| Shares outstanding (cover) | 82.8M+5.0% | 78.9M+3.0% | 76.6M+3.8% | 73.8M+3.4% | 71.4M+1.5% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 711M+760.4% | -108M+32.0% | -158M+55.6% | -357M-41.9% | -251M-29.5% | ||
| Depreciation & amortization | 38.8M-48.7% | 75.7M-68.0% | 237M+83.6% | 129M+100.9% | 64.1M+47.5% | |
| Intangible amortization | 24.7M-59.3% | 60.7M-72.7% | 223M+91.0% | 117M+112.9% | 54.8M+48.4% | |
| Share-based compensation | 74.5M-0.1% | 74.6M-26.6% | 102M-7.9% | 110M+6.6% | 104M+47.2% | |
| Deferred income taxes | -3.00K+100.0% | -55.9M-19.1% | -46.9M-36.9% | -34.3M-9191.8% | 377K-93.6% | |
| Change in inventory | 53.9M+974.4% | -6.16M-175.3% | 8.18M+22.7% | 6.67M+470.4% | -1.80M+2.2% | |
| -862M-2051.0% | 44.2M+125.0% | -177M-160.9% | 290M+32.4% | 219M+139.0% | ||
| Capital expenditure | 8.86M+36.3% | 6.50M-77.1% | 28.4M-11.2% | 32.0M+13.5% | 28.2M+58.1% | |
| Free cash flow | 702M+715.1% | -114M+38.9% | -187M+51.9% | -389M-39.0% | -280M-31.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 70.0K-99.8% | 28.1M | — | — | — | |
| 331M+29.4% | 256M-60.4% | 646M+284.9% | 168M+704.5% | 20.9M-96.9% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | — | — | — | — | -7.82M-201.7% | |
| Net change in cash | 203M+9.7% | 185M-41.1% | 314M+218.5% | 98.7M+617.0% | -19.1M+75.9% | |
| Interest paid | 5.70M-2.1% | 5.82M-83.9% | 36.1M+95.7% | 18.5M+92.6% | 9.59M-2.2% | |
| Income taxes paid | 36.9M+110.0% | 17.6M+24.0% | 14.2M+187.6% | 4.92M-36.1% | 7.71M-70.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 6.29B+76.6% | 3.56B+71.2% | 2.08B-24.2% | 2.74B-3.5% | 2.84B-33.8% | |
| P/E | 9.2× | — | — | — | — | |
| P/S | 3.6×-17.7% | 4.4×+69.4% | 2.6×-33.8% | 3.9×-25.4% | 5.3×-53.2% | |
| P/B | — | — | — | — | 1976.6×+22098.1% | |
| P/FCF | 9.0× | — | — | — | — | |
| Earnings yield | 10.9% | — | — | — | — | |
| FCF yield | 11.2% | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: PTCT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PTCT filings on SEC EDGAR → Not investment advice.